pharma news

News

UK biotech sees "strong finish" to 2025 financing

2025 was a challenging year for the UK biotech sector, but it ended the year with signs of "renewed confidence," says the BIA industry body.

News

Introducing the Sunday Times Tech 100: Life sciences part 3

In our third and final report on the 2026 Sunday Times Tech 100, we focus on the remaining crop of life sciences companies in the hardware category.

News

China clears its first drug for chronic hepatitis D

Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus.

News

Boehringer signs €1bn+ deal for Simcere IBD candidate

Boehringer Ingelheim has sourced an IL-23p19xTL1A bispecific antibody for inflammatory bowel disease, from China's Simcere, for €42m upfront.

News

Vaccination fall costs UK its measles elimination status

The UK has lost its measles elimination status, according to the WHO, due to a spike in cases in 2024 and a fall in vaccination coverage.

News

Roche claims midstage win for obesity injectable

Roche reports weight loss of up to 22.5% with its injectable GIP/GLP-1 agonist obesity drug, setting up phase 3, but will it be too late to the table?

UK biotech sees "strong finish" to 2025 financing

Introducing the Sunday Times Tech 100: Life sciences part 3

China clears its first drug for chronic hepatitis D

Boehringer signs €1bn+ deal for Simcere IBD candidate

Vaccination fall costs UK its measles elimination status

Roche claims midstage win for obesity injectable

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

pharma news

Editor's Picks